Description
A Study to evaluate an investigational drug designed to inhibit receptors that are believed to contribute to migraine attacks.
This study lasts up to 55 weeks, in which participants will be screened, go through two phases of treatment and have a follow-up visit.
Study Treatment Phase – Part One – 12 Weeks
Participants will be randomly assigned to receive the investigational drug or a placebo.
The post Frequent Migraine Prevention Study appeared first on Palm Beach Neurological Center.
This post first appeared on News & Announcements Archives - Palm Beach Neurolo, please read the originial post: here